REG - Abbott Laboratories - Statement of Changes in Director/PDMR Shareholding <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

30/10/2014 09:31

RNS Number : 0899T
Abbott Laboratories
30 September 2014
Notification to RNS
Company:  Abbott Laboratories
TIDM: ABT
Headline:  Abbott Laboratories Files Form 3 and Form 4
Abbott Laboratories (the "Company")
30 September 2014
Abbott Laboratories Files Form 3 and Form 4
The Company informs its shareholders that on 30 September 2014, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, a Form 3 (the report on Form 3 being an initial statement of beneficial ownership of securities) ("Form 3") and a Form 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") was filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 3 and 4 can be found on the SEC website at http://www.sec.gov.
A copy of the Forms 3 and 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial, Brian Yoor, +1-224-667-6343, or Tina Ventura, +1-224-668-7606, or Media, Melissa Brotz, +1-224-668-3456, or Scott Stoffel, +1-224-668-5201.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSEAFNEDAXLEAF